PFBT
NRIX icon

Parkside Financial Bank & Trust’s Nurix Therapeutics NRIX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38K Hold
57
– – ﹤0.01% 2306
2026
Q1 		$884 Sell
57
-35
-38% -$580 ﹤0.01% 2395
2025
Q4 		$1.75K Buy
92
+90
+4,500% +$1.29K ﹤0.01% 2152
2025
Q3 		$19 Sell
2
-98
-98% -$1.02K ﹤0.01% 2696
2025
Q2 		$1.14K Buy
+100
New +$1.08K ﹤0.01% 2220

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parkside Financial Bank & Trust's NRIX Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Nurix Therapeutics (NRIX) position steady in Q2 2026 at 57 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #2306.

Parkside Financial Bank & Trust first reported a position in NRIX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.75K in Q4 2025. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Parkside Financial Bank & Trust held 57 shares of Nurix Therapeutics worth $1.38K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Nurix Therapeutics share count unchanged in Q2 2026.
  • Nurix Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2306 holding.
  • Parkside Financial Bank & Trust first reported a position in Nurix Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Nurix Therapeutics position peaked at $1.75K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.